The rationale for other targets that have not been previously tested using monoclonal antibodies, such as the isoform variant 6 (CD44v6) [31, 32], CD70 [33–35], and APRIL [36] mainly draws from their expression in a significant fraction of MM samples. Here, CD70 is linked to Miyoshi myopathy.